Table 3.

Clinical safety outcome measures

	Nurse-C	LOGIC-C	P value
Patients	773	777
Length of ICU stay, median (IQR), days	3 (2–6)	3 (2–6)	0.39
Length of hospital stay, median (IQR), days	12 (8–23)	12 (8–23)	0.18
Mortality in the ICU, n (%)	41 (5.30)	47 (6.05)	0.61
Mortality in the hospital, n (%)	84 (10.81)	72 (9.31)	0.35
Mortality at 90 days, n (%)	89 (11.71)	91 (11.51)	0.93
Incidence of new infections in the ICU, n (%)	117 (15.14)	104 (13.38)	0.35
Ventilator days, median (IQR), days	1 (1–2)	1 (1–3)	0.85
EQ-5D index value at ICU discharge, median (IQR)	0.28 (0.13–0.58)	0.29 (0.13–0.58)	0.59
EQ-5D index value at 90 days, median (IQR)	0.73 (0.56–1)	0.73 (0.56–1)	0.58
EQ-5D VAS score at ICU discharge, median (IQR)	0.60 (0.50–0.70)	0.60 (0.50–0.70)	0.42
EQ-5D VAS score at 90 days, median (IQR)	0.70 (0.60–0.80)	0.70 (0.60–0.80)	0.97

Data are mean (SD), median (IQR) or n (%). LOGIC-C patients randomized to algorithm-guided blood glucose control, Nurse-C patients randomized to blood glucose control by trained nurses, EQ-5D Euroqol-5D, VAS visual analog scale